RYTM fund manager activity
Rhythm Pharmaceuticals, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q3 2023 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | New | 203,618 | $22,608,000 | 0.52% | Aug 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 5,516 | $612,441 | 0.00% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Trimmed | 4,848 | $421,631 | 0.00% | May 15, 2026 |